The National Institutes of Health (NIH) Office of Biotechnology Activities (OBA) will conduct a site visit at Emory’s main campus on March 18th, 2014. During the site visit, the team will review and evaluate the institution’s compliance with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. The site visit will primarily focus on evaluation of the University’s Institutional Biosafety Committee and the oversight program for research subject to the NIH Guidelines.
-
Recent Articles for Emory’s Research Administrator
- Federal Agency Updates – NIH and NSF
- NIH Closeout Procedures (From the PI Perspective)
- IACUC Updates – December 2022
- Preparing Research Laboratories for Winter Recess
- New Proposal & Award Policies and Procedures Guide (PAPPG) Now Available
- Preparing Supplemental Funding Requests in Research.gov and Upcoming FastLane Proposal Decommissioning Deadlines
- OSP Update: GA Department of Public Health Indirect Cost Rate Policy
- IACUC Updates (October 2022)
- Award Closeout Announcement
- eDisclose for Research Disclosures
New from NIH
- Encouraging Use of the PHS Assignment Request Form in Applications January 27, 2023You have likely come across the Public Health Service (PHS) assignment request form when putting together your grant application. It’s optional, but we encourage applicants to fill it out.Mike Lauer
- Encouraging Use of the PHS Assignment Request Form in Applications January 27, 2023
News from the Office of Technology Transfer
Emails from EHSO